Who filed this patent? The US Department of Health and Human Services (HHS). Yes, the government of the United States filed USA Patent US6630507B1 and yes in 1999. As an existing or prospective investor what else do you need to know as to where this industry is headed and on the medical front in particular. In past content, I have listed the many medical conditions said to be treated effectively by cannabis (no claims are being made by myself or by CannaInvestor Magazine) and stressed what it would mean to an investor if even one of those conditions was proven to be treated effectively by cannabis. I introduced you to chronic inflammation as the unifying theory of disease – according to many experts. And I reminded you how one of the functions of the Endogenous Cannabinoid System (or endocannabinoid system) is to modulate blood glucose as well as inflammation. Let’s now look at another Canadian statistic. Overall, it cannot be denied that as a population, Canadians tend to be more progressive with respect to accepting cannabis as a form of medicine. A recent poll in that country showed that two-thirds of Canadians would prefer a cannabis based prescription over traditional pharmaceutical alternatives. As an investor think of what that translates to once there are DINs and more widespread medical benefits coverage regardless of the country. You already know from our past content that Germany leads the way on that front with government paid for coverage of medical cannabis.